PL BioScience announces Distributorship Agreement with SPI PL BioScience announces Exclusive Distributorship Agreement with Summit Pharmaceuticals International (SPI) PL BioScience GmbH is proud to announce an exclusive distribution agreement for the Japanese market with Summit Pharmaceuticals International Corporation (SPI) to support local availability of Gamma-Irradiated ELAREM™ Ultimate-FD
PL BioScience announces Material Qualification Certificate from Japan's PMDA PL BioScience announces Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS from Japan's PMDA PL BioScience announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has issued a Material Qualification Certificate for ELAREM™ Ultimate-FD PLUS (GMP Grade), the company’s processed cell culture
The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements, including redirection of HPL customers from Macopharma to PL BioScience. PL BioScience GmbH, a German life science company specializing in the production and
